The online home for the primary care professionals managing patients with cardiovascular disease, diabetes and related diseases.

Practical tools for CVD prevention: FH implementation guidance

Practical tools for CVD prevention: FH implementation guidance

Publication date: Thursday, 08 August 2019
Contributor(s): Simon Williams, Professor Jamie Waterall, Dr Rhosyn Harris, Leyla Hannbeck, Jenny Hargrave, Professor Huon H Gray, Professor Steve E Humphries, Alexandra Pickard, Joanne Whitmore

Familial hypercholesterolaemia (FH) is a common monogenetic condition that causes high levels of cholesterol in the blood, resulting in an increased risk of heart disease at an early age. FH affects around one in every 270 people. That means that in England around 160,000 adults and 40,000 children under 18 years are likely to have FH, though only around 3,000 have been diagnosed by DNA testing. This article discusses the new implementation guide, which is designed to improve the identification and treatment of people with FH.
Topics covered:
Category: Editorial
Edition: Volume 11 Number 1 February 2019
Print edition page(s): S42
Contributor(s): Simon Williams, Professor Jamie Waterall, Dr Rhosyn Harris, Leyla Hannbeck, Jenny Hargrave, Professor Huon H Gray, Professor Steve E Humphries, Alexandra Pickard, Joanne Whitmore

Article search and filter